After exclusion of women with less than @ months of follow-up or those who were HPV-@ / @ DNA-positive at enrolment ( for the HPV-@ / @ endpoint ) , we calculated vaccine efficacy against one-time detection of incident HPV infections after three , two , and one dose ( s ) .